|
KIAA1524 expression based on
|
| Comparison | Statistical significance |
| Normal-vs-Primary | 3.75089959092634E-10 |
|
Note
Cancer stage information is not available for 2 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
3.06769998292822E-09 |
| Normal-vs-Stage2 |
3.50290019213162E-10 |
| Normal-vs-Stage3 |
9.36289934472256E-11 |
| Normal-vs-Stage4 |
1.83150050681036E-10 |
| Stage1-vs-Stage2 |
1.518620E-01 |
| Stage1-vs-Stage3 |
5.739500E-02 |
| Stage1-vs-Stage4 |
4.453500E-02 |
| Stage2-vs-Stage3 |
9.947000E-01 |
| Stage2-vs-Stage4 |
6.373800E-01 |
| Stage3-vs-Stage4 |
5.934200E-01 |
|
|
Note
Patient race information is not available for 92 samples and one samples from American Indians not included in the above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
9.10409969634429E-10 |
| Normal-vs-AfricanAmerican |
6.25799999999233E-05 |
| Normal-vs-Asian |
1.91430005180848E-09 |
| Caucasian-vs-AfricanAmerican |
7.194400E-01 |
| Caucasian-vs-Asian |
5.141400E-01 |
| AfricanAmerican-vs-Asian |
4.595800E-01 |
|
|
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
1.22600041230214E-10 |
| Normal-vs-Female |
7.36830041425662E-10 |
| Male-vs-Female |
2.296000E-01 |
|
|
Note
Seventeen samples from patient below 21 years not considered in above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
1.94039999623641E-08 |
| Normal-vs-Age(41-60Yrs) |
2.69979594236247E-11 |
| Normal-vs-Age(61-80Yrs) |
3.56410012614106E-10 |
| Normal-vs-Age(81-100Yrs) |
2.832400E-02 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
2.041300E-03 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
6.546200E-02 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
5.679600E-01 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
4.694400E-01 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
1.036030E-01 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
2.019000E-01 |
|
|
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Classical-VS-Tall |
6.339200E-01 |
| Classical-VS-Follicular |
4.411700E-02 |
| Classical-VS-Other |
3.494400E-01 |
| Classical-VS-Normal |
4.83210005342016E-09 |
| Tall-VS-Follicular |
4.862400E-01 |
| Tall-VS-Other |
5.563000E-01 |
| Tall-VS-Normal |
2.86479999944689E-07 |
| Follicular-VS-Other |
8.179800E-01 |
| Follicular-VS-Normal |
2.04489980504263E-10 |
| Other-VS-Normal |
2.30969999999164E-05 |
|
|
Note
Cancer in nearby lymph nodes cannot be measured (NX) in 50 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
8.47409920012865E-11 |
| Normal-vs-N1 |
2.29560004338936E-09 |
| N0-vs-N1 |
7.707000E-01 |
|
|
